Taysha Gene Therapies, Inc.
← Back to TSHA Overview

Taysha Gene Therapies, Inc. (TSHA)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-15.78

Financial Fundamentals

TSHAQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2019-12-31-81.84
2020-03-31-16.80
2020-06-30-9.79
2020-09-30-4.37
2020-12-31-13.68
2021-03-31-5.86
2021-06-30-4.85
2021-09-30-3.46
2021-12-31-2.20
2022-03-31-1.24
2022-06-30-1.10
2022-09-30-0.74
2022-12-31-0.57
2023-03-31-0.72
2023-06-30-0.43
2023-09-30-0.85
2023-12-311.73
2024-03-31-6.82
2024-06-30-6.29
2024-09-30-5.27
2024-12-31-4.72
2025-03-31-4.35
2025-06-30-6.40
2025-09-30-8.82
2025-12-31-15.78

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.